Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Timo Pietilä"'
Publikováno v:
Journal of child neurology. 31(8)
This population-based cross-sectional study evaluates the clinical value of electroretinography and visual evoked potentials in childhood brain tumor survivors. A flash electroretinography and a checkerboard reversal pattern visual evoked potential (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cab148f9cd04d23e5b533b70004cb53d
https://pubmed.ncbi.nlm.nih.gov/26945030
https://pubmed.ncbi.nlm.nih.gov/26945030
Autor:
Jukka-Pekka Ahonen, Matti Latvala, Timo Metsä-Ketelä, Hannu Alho, G. Molnar, Jukka Peltola, Kimmo Lönnrot, Timo PietilÄ
Publikováno v:
Free Radical Biology and Medicine. 21:211-217
Free radicals are thought to be involved in the onset of neuronal disturbances such as Alzheimer's disease, Parkinson's disease, and neuronal ceroid lipofuscinosis. It is also assumed that they play a role in cerebral injury caused by ischemia or tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c48a77e7fdbbf29b29fae190b9b02041
https://doi.org/10.1016/0891-5849(95)02207-4
https://doi.org/10.1016/0891-5849(95)02207-4
Autor:
Timo, Pietilä
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 118(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ba56f49a4ae4ccd72c955bb3145c2f5
https://pubmed.ncbi.nlm.nih.gov/12238002
https://pubmed.ncbi.nlm.nih.gov/12238002
Autor:
H. Frey, Juha O. Rinne, Timo Koivula, Hannu Kalimo, Timo Pietilä, Kari M. Mattila, Pekka Laippala, Terho Lehtimäki, Matias Röyttä
Publikováno v:
Journal of medical genetics. 37(10)
Alzheimer's disease (AD) and Parkinson's disease (PD) are genetically heterogeneous. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) genes may modify the risk of these disorders. We investigated whether common polymorphisms pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30f776695473398bdd56ce87aa9b18a4
https://pubmed.ncbi.nlm.nih.gov/11015454
https://pubmed.ncbi.nlm.nih.gov/11015454
Autor:
Sylwia Libard, Svetlana N Popova, Rose-Marie Amini, Vesa Kärjä, Timo Pietiläinen, Kirsi M Hämäläinen, Christer Sundström, Göran Hesselager, Michael Bergqvist, Simon Ekman, Maria Zetterling, Anja Smits, Pelle Nilsson, Susan Pfeifer, Teresita Diaz de Ståhl, Gunilla Enblad, Fredrik Ponten, Irina Alafuzoff
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e108861 (2014)
Human cytomegalovirus (HCMV) has been indicated being a significant oncomodulator. Recent reports have suggested that an antiviral treatment alters the outcome of a glioblastoma. We analysed the performance of commercial HCMV-antibodies applying the
Externí odkaz:
https://doaj.org/article/070544a40de84917813e7cbb5396fefc